Apellis Pharmaceuticals Inc. Raises Series C Financing
August 21, 2013
Louisville, Kentucky – August 21st, 2013 – Rock Spring Ventures has increased its investment in Apellis Pharmaceuticals Inc., an early-stage biotechnology company focused on developing